US CDC reports 21 Oropouche virus cases among travellers returning from Cuba

Sign up now: Get ST's newsletters delivered to your inbox

The Oropouche virus is spread by midges and has caused two deaths so far in 2024.

The Oropouche virus is spread through the bite of an insect known as a midge, and it has caused two deaths so far in 2024.

PHOTO: EPA-EFE

Follow topic:

WASHINGTON - The US Centres for Disease Control and Prevention (CDC) said on Aug 27 that a total of 21 Oropouche virus disease cases among US travellers returning from Cuba have been reported as at Aug 16.

The Oropouche virus is spread primarily through the bite of an insect known as a midge. Symptoms of the disease include headache, fever and muscle aches and joint pains, but the virus is rarely fatal.

Most patients reported their symptoms between May and July.

Overall, three patients were hospitalised, and no deaths were reported, the agency said in its Morbidity and Mortality Weekly Report.

A dire economic crisis in Cuba has made it difficult to control the spread of Oropouche. Frequent power outages mean many people sleep with windows open during the hot Caribbean summer. Few Cubans have access to insect repellent, and fumigation efforts have been stymied by fuel shortages.

Health officials in Cuba first began to report cases of the virus in May, and say it has spread quickly from rural areas to urban centres, including the capital Havana, a top tourist destination.

Cuba’s health ministry said last week it had registered more than 400 cases of Oropouche on the island this year, though reports around Havana suggest a marked increase in recent weeks.

Earlier in August, the CDC issued a health alert to notify clinicians and the public health authorities of an increase in the disease in the Americas region that has caused two deaths so far in 2024.

The authorities in Bolivia, Brazil, Colombia, Cuba and Peru have reported at least 8,000 locally acquired cases since late last year.

Currently, there are no specific treatments or vaccines available for the disease. REUTERS

See more on